Skip to Content

XTAMPZA ER 13.5 mg (Xtampza ER 13.5 mg)

Generic Name: oxycodone

Pill with imprint XTAMPZA ER 13.5 mg is Orange & White, Capsule-shape and has been identified as Xtampza ER 13.5 mg. It is supplied by Collegium Pharmaceutical, Inc..

Xtampza ER is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. FDA has not classified the drug for risk during pregnancy. Xtampza ER 13.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for XTAMPZA ER 13.5 mg

Xtampza ER 13.5 mg XTAMPZA ER 13.5 mg

Xtampza ER

Generic Name
oxycodone
Imprint
XTAMPZA ER 13.5 mg
Strength
13.5 mg
Color
Orange & White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
N - Not classified
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Collegium Pharmaceutical, Inc.
National Drug Code (NDC)
24510-0115
Inactive Ingredients
yellow wax, carnauba wax, magnesium stearate, silicon dioxide, titanium dioxide, water, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.